Vas Narasimhan
PulseAugur coverage of Vas Narasimhan — every cluster mentioning Vas Narasimhan across labs, papers, and developer communities, ranked by signal.
2 day(s) with sentiment data
-
Anthropic's Trust Appoints Board Majority, Influencing Model Releases
Anthropic's Long-Term Benefit Trust has now appointed a majority of the company's board members, a move that could impact future AI model releases. The trust, composed of financially disinterested individuals, has the p…
-
Anthropic's $2T IPO highlights unique trustee-controlled governance
Anthropic is preparing for a potential $2 trillion IPO, which is bringing its unique governance structure under intense public scrutiny. The company's Long-Term Benefit Trust (LTBT), composed of external advisors, holds…
-
Anthropic launches drug discovery programs for neglected diseases
Anthropic is initiating its own drug discovery initiatives, focusing on diseases that large pharmaceutical companies deem unprofitable. This move aims to accelerate the development timeline for these neglected condition…
-
Anthropic adds Novartis CEO Vas Narasimhan to Board of Directors
Anthropic's Long-Term Benefit Trust has appointed Vas Narasimhan, CEO of Novartis, to its Board of Directors. Narasimhan's extensive experience in developing and approving new medicines in a highly regulated industry is…